These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 903332)

  • 1. Bacteroides fragilis infections of the urinary tract.
    Garcia JA; Prieto J; Garcia JE; Saenz MC
    J Antimicrob Chemother; 1977 Sep; 3(5):521-2. PubMed ID: 903332
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro sensitivity tests and in-vivo efficacy of cephalosporins against Bacteroides fragilis.
    Brook I
    J Antimicrob Chemother; 1990 Jul; 26(1):158-61. PubMed ID: 2211440
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaerobic urinary tract infection owing to Bacteroides fragilis in a chronic hemodialysis patient.
    Swamy AP; Cestero RV; Bentley DW; Linke CA
    J Urol; 1980 Feb; 123(2):298-300. PubMed ID: 7354547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Sydenham TV; Jensen BH; Petersen AM; Krogfelt KA; Justesen US
    Int J Antimicrob Agents; 2017 May; 49(5):573-578. PubMed ID: 28366659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infections caused by Bacteroides fragilis resistant to clindamycin: 2 further cases].
    Andrieu J; Kwantes M; Lapeyrere X; Gardon JD
    Nouv Presse Med; 1978 Feb; 7(7):571-2. PubMed ID: 643586
    [No Abstract]   [Full Text] [Related]  

  • 6. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
    Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
    Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
    Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A
    J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem resistance in Bacteroides fragilis.
    Ang L; Brenwald NP; Walker RM; Andrews J; Fraise A
    J Antimicrob Chemother; 2007 May; 59(5):1042-4. PubMed ID: 17363423
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility.
    Hawser SP; Hackel M; Hoban DJ
    J Antimicrob Chemother; 2010 Apr; 65(4):803-4. PubMed ID: 20130025
    [No Abstract]   [Full Text] [Related]  

  • 12. [Appearance of metronidazole resistance in Bacteroides fragilis].
    Chardon H; Ratignier A; Luneau R; Garrigues B
    Nouv Presse Med; 1977 Jun; 6(24):2165. PubMed ID: 905136
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
    Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
    Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteroides fragilis meningitis successfully treated with metronidazole after a previous failure with thiamphenicol.
    Soriano F; Aguado JM; Tornero J; Fernandez-Guerrero ML; Gómez-Garcés JL
    J Clin Microbiol; 1986 Sep; 24(3):472-3. PubMed ID: 3760141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteroides fragilis septicemia during cefamandole therapy.
    Righter J
    Can Med Assoc J; 1981 Sep; 125(5):422, 424. PubMed ID: 7284925
    [No Abstract]   [Full Text] [Related]  

  • 17. First Hungarian case of an infection caused by multidrug-resistant Bacteroides fragilis strain.
    Urbán E; Horváth Z; Sóki J; Lázár G
    Anaerobe; 2015 Feb; 31():55-8. PubMed ID: 25285854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
    Borobio MV; Domínguez MC; Pallares JA; Perea EJ
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriology of urinary tract infections and the effectiveness of antimicrobials against the urinary pathogens.
    Sengupta SR; Bansal MP; Deshpande PK; Sharma KD
    J Assoc Physicians India; 1972 Oct; 20(10):755-9. PubMed ID: 4570011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.